India gets 3rd Coronavirus Vaccine as DCGI approves Russia’s “Sputnik V”

Current GK ( Master) Health and Diseases

India’s drug regulator, Drugs Controller General of India (DCGI) has approved Russian Covid-19 vaccine “Sputnik V” on April 13, 2021, for use in the country under ‘restricted use in emergency situations’.
Sputnik V will be the third Covid-19 vaccine in India.
Besides this, the other two vaccines approved in India are Covishield, manufactured by Serum Institute of India (SII), and Covaxin, manufactured by Bharat Biotech International Limited (BBIL). These vaccines are approved under “emergency-use authorisation (EUA)” by the regulator.
India is the 60th country to approve the use of Sputnik V against coronavirus.
Over 850 million doses of the vaccine are proposed to be produced in India annually.